{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:03:20Z","timestamp":1784027000416,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.jcf.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T18:12:56Z","timestamp":1538244776000},"page":"265-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His"],"prefix":"10.1016","volume":"18","author":[{"given":"Katherine","family":"Keenan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tullis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Gonska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6416","key":"10.1016\/j.jcf.2018.09.002_bb0005","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/362160a0","article-title":"Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties","volume":"362","author":"Sheppard","year":"1993","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.jcf.2018.09.002_bb0010","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1093\/hmg\/8.13.2339","article-title":"Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9","volume":"8","author":"Niksic","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jcf.2018.09.002_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/ng0293-151","article-title":"Genetic basis of variable exon 9 skipping in cystic fibrosis transmembrane conductance regulator mRNA","volume":"3","author":"Chu","year":"1993","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.jcf.2018.09.002_bb0020","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng1193-274","article-title":"A mutation in CFTR produces different phenotypes depending on chromosomal background","volume":"5","author":"Kiesewetter","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/j.jcf.2018.09.002_bb0025","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJM199506013322204","article-title":"Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens","volume":"332","author":"Chill\u00f3n","year":"1995","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.jcf.2018.09.002_bb0030","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/GIM.0b013e31818e55a2","article-title":"Clinical practice and genetic counseling for cystic fibrosis and CFTR-related disorders","volume":"10","author":"Moskowitz","year":"2008","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.jcf.2018.09.002_bb0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jcf.2005.09.009","article-title":"Delayed diagnosis of cystic fibrosis associated with R117H on a background of 7T polythymidine tract at intron 8","volume":"5","author":"Peckham","year":"2006","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2018.09.002_bb0040","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jmedgenet-2012-101427","article-title":"CFTR p.Arg117His associated with CBAVD and other CFTR-related disorders","volume":"50","author":"Thauvin-Robinet","year":"2013","journal-title":"J Med Genet"},{"key":"10.1016\/j.jcf.2018.09.002_bb0045","unstructured":"The Clinical and Functional Translation of CFTR (CFTR2); available at http:\/\/cftr2.org. @ Copyright 2011 US CF Foundation, Johns Hopkins University, The Hospital for Sick Children. Accessed July 14, 2017."},{"key":"10.1016\/j.jcf.2018.09.002_bb0050","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.arcped.2005.04.064","article-title":"Cystic fibrosis: the French neonatal screening organization, preliminary results [in French]","volume":"12","author":"Munck","year":"2005","journal-title":"Arch Pediatr"},{"issue":"6","key":"10.1016\/j.jcf.2018.09.002_bb0055","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1542\/peds.2014-2081","article-title":"Inconclusive diagnosis of cystic fibrosis after newborn screening","volume":"135","author":"Ooi","year":"2015","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.jcf.2018.09.002_bb0060","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1136\/adc.88.10.886","article-title":"Genetic counselling after carrier detection by newborn screening when one parent carries DeltaF508 and the other R117H","volume":"88","author":"Curnow","year":"2003","journal-title":"Arch Dis Child"},{"issue":"11","key":"10.1016\/j.jcf.2018.09.002_bb0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jmg.2009.067215","article-title":"The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening","volume":"46","author":"Thauvin-Robinet","year":"2009","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.jcf.2018.09.002_bb0070","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck","year":"2014","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2018.09.002_bb0075","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1016\/j.jcf.2015.01.010","article-title":"Ivacaftor as salvage therapy in a patient with cystic fibrosis genotype F508del\/R117H\/IVS8-5T","volume":"14","author":"Carter","year":"2015","journal-title":"J Cyst Fibros"},{"issue":"7","key":"10.1016\/j.jcf.2018.09.002_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(15)00201-5","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial","volume":"3","author":"Moss","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.jcf.2018.09.002_bb0085","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/thoraxjnl-2011-201454","article-title":"Comparing the American and European diagnostic guidelines for cystic fibrosis: same disease, different language?","volume":"67","author":"Ooi","year":"2012","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.jcf.2018.09.002_bb0090","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.00080312","article-title":"Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations","volume":"40","author":"Quanjer","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2018.09.002_bb0095","article-title":"Diagnosis of Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis Foundation","author":"Farrell","year":"2017","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2018.09.002_bb0100","series-title":"Recommendations for the classification of diseases as CFTR-related disorders","first-page":"S86","author":"Bombieri","year":"2011"},{"issue":"3","key":"10.1016\/j.jcf.2018.09.002_bb0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jcf.2014.09.006","article-title":"Nasal potential difference: best or average result for CFTR function as diagnostic criteria for cystic fibrosis?","volume":"14","author":"Keenan","year":"2015","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2018.09.002_bb0110","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1183\/09031936.01.00057001","article-title":"Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C","volume":"17","author":"Massie","year":"2001","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.jcf.2018.09.002_bb0115","doi-asserted-by":"crossref","first-page":"00056","DOI":"10.1183\/23120541.00056-2016","article-title":"Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His","volume":"3","author":"Shteinberg","year":"2017","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.jcf.2018.09.002_bb0120","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1086\/381001","article-title":"Variation in a repeat Sequence Determines whether a Common Variant of the Cystic Fibrosis Transmembrane Conductance Regulator Gene is Pathogenic or Benign","volume":"74","author":"Groman","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.jcf.2018.09.002_bb0125","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MCP.0b013e32834ba899","article-title":"Nongenetic influences on cystic fibrosis outcomes","volume":"17","author":"Schechter","year":"2011","journal-title":"Curr Opin Pulm Med"},{"issue":"5","key":"10.1016\/j.jcf.2018.09.002_bb0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/ng.2221","article-title":"Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis","volume":"44","author":"Sun","year":"2012","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.jcf.2018.09.002_bb0135","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00439-013-1363-7","article-title":"Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities","volume":"133","author":"Li","year":"2014","journal-title":"Hum Genet"},{"key":"10.1016\/j.jcf.2018.09.002_bb0140","doi-asserted-by":"crossref","first-page":"8382","DOI":"10.1038\/ncomms9382","article-title":"Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis","volume":"6","author":"Corvol","year":"2015","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.jcf.2018.09.002_bb0145","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.gim.0000223549.57443.16","article-title":"CFTR 5T variant has a low penetrance in females that is partially attributable to its haplotype","volume":"8","author":"Sun","year":"2006","journal-title":"Genet Med"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318308002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199318308002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:39:59Z","timestamp":1761601199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199318308002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1569199318308002"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2018.09.002","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypic spectrum of patients with cystic fibrosis and cystic fibrosis-related disease carrying p.Arg117His","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2018 Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}